Live Breaking News & Updates on Anuron kumar mitra
Stay updated with breaking news from Anuron kumar mitra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
India's health minister said on Tuesday that a government panel of experts was looking into a Delta coronavirus subvariant, AY.4.2, that has been detected in the United Kingdom.
U.S., India's Biological E. finalise $50 million financing deal for COVID-19 shots whbl.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from whbl.com Daily Mail and Mail on Sunday newspapers.
The United States and India's Biological E. Ltd said on Monday they had finalised a financing arrangement for $50 million to expand the vaccine maker's capacity to produce COVID-19 shots.
The United States and India's Biological E. Ltd said on Monday they had finalised a financing arrangement for $50 million to expand the vaccine maker's capacity to produce COVID-19 shots.
The United States, through its International Development Finance Corporation, and India's Biological E. Ltd said on Monday they have finalised a financing arrangement for $50 million to expand the vaccine maker's capacity to produce COVID-19 shots. (Reporting by Anuron Kumar...
India's Reliance Industries Ltd said on Thursday that a required majority of its shareholders have passed a resolution to appoint Saudi Aramco Chairman Yasir Al-Rumayyan as an independent director to the conglomerate's board.
India's CRED said on Tuesday it had raised $251 million in a new funding round led by existing investors and private equity firms Tiger Global and Falconedge, valuing the fintech company at $4.01 billion.
India's CRED said on Tuesday it had raised $251 million in a new funding round led by existing investors and private equity firms Tiger Global and Falconedge, valuing the fintech company at $4.01 billion.
The World Health Organization on Monday asked for further data from India's Bharat Biotech to consider the company's request for an emergency-use listing for its COVID-19 shot, saying the WHO could not "cut corners" in making a decision.